Words of wisdom. Re: randomized phase III Trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
Malmström
Per-Uno
PU
University Hospital, Uppsala, Sweden. per-uno.malmstrom@kirurgi.uu.se